Skip to main content
logo
Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.552
-0.028 (-1.10%)
At close: Oct 2, 2026, 4:00 PM EDT
2.560
+0.008 (0.33%)
After-hours: Oct 2, 2026, 4:10 PM EDT

Kiora Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1610144619
Market Cap Growth
70.91%-30.96%250.17%-34.81%-67.75%-29.68%
Enterprise Value
-0-9-15-118
Last Close Price
2.581.973.304.7030.87543.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--3.91---
PS Ratio
--0.88---
PB Ratio
0.970.600.550.660.541.31
P/TBV Ratio
0.960.600.550.670.551.33
P/FCF Ratio
--1.65---
P/OCF Ratio
--1.64---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.000.020.010.01
Debt / EBITDA Ratio
--0.01---
Debt / FCF Ratio
--0.01---
Net Debt / Equity Ratio
-0.98-1.04-1.04-0.38-0.51-0.52
Net Debt / EBITDA Ratio
1.701.77-4.770.270.550.73
Net Debt / FCF Ratio
1.921.66-3.130.250.560.71
Asset Turnover
--0.64---
Quick Ratio
8.335.624.602.762.245.21
Current Ratio
8.975.994.942.902.355.59
Return on Equity (ROE)
-56.36%-51.74%22.56%-142.88%-104.54%-113.30%
Return on Assets (ROA)
-21.92%-19.47%13.90%-33.54%-34.55%-37.30%
Return on Invested Capital (ROIC)
-2482.70%-254.39%-186.67%-171.87%-131.74%
Return on Capital Employed (ROCE)
-45.70%-45.90%18.30%-72.00%-69.60%-57.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-67.71%-111.57%25.56%-311.53%-220.45%-72.08%
FCF Yield
-53.09%-103.72%60.81%-237.92%-169.24%-56.21%
Buyback Yield / Dilution
-17.44%-1.01%-666.73%-561.21%-203.73%-110.04%
SEC Filings: 10-K · 10-Q